Govt rejects EFTA’s data exclusivity demand to protect generic drug cos
India will continue to protect the interests of its generic drug firms and has rejected European Free Trade Association (EFTA) nations’ demand to keep “data...
Continue ReadingViatris gets global Minimised Risk of AMR Certification
Viatris announced that its Aurangabad, India, facility has received certification from the British Standards Institution (BSI) for meeting a new industry standard on Minimised Risk...
Continue ReadingCDSCO issues sampling guidelines to ensuring quality and efficacy of drugs, cosmetics
The Central Drugs Standard Control Organisation (CDSCO) has issued new guidelines for effective surveillance for quality and efficacy of drugs and cosmetics available in the...
Continue ReadingSun Pharma included in S&P Global Sustainability Yearbook 2024
Sun Pharmaceutical Industries has been included in the S&P Global Sustainability Yearbook 2024. Within respective industries, this Yearbook aims to distinguish those companies that have...
Continue ReadingKarnataka pharma gives top priority to implement Revised Schedule M
The pharmaceutical industry in Karnataka is giving top priority to strengthen its compliance efforts for the Revised Schedule M. The state which is already known...
Continue ReadingPatient declared cancer free using Indian-made CAR-T cell therapy. Know what it is
A patient has become the first to be cured using India’s CAR-T cell therapy, an indigenous cancer treatment, which was recently approved for commercial use...
Continue ReadingCipla eyes acquisitions, inorganic partnerships in US market
Drug major Cipla is eyeing acquisitions and inorganic partnerships in the US market while consolidating its presence across segments in the domestic market. The Mumbai-based...
Continue ReadingConsensus Guidelines for the Management of Head & Neck Cancer recognised among 13 worldwide clinical practice guidelines
The Consensus Guidelines for the Management of Head and Neck Cancer (HNC), developed under the aegis of Oral Cancer Task Force (OCTF) supported by the...
Continue ReadingGlenmark partners with Pfizer to launch Abrocitinib in India
Pfizer and Glenmark Pharmaceuticals have joined hands to launch abrocitinib, an oral advanced systemic treatment for moderate-to-severe atopic dermatitis (AD), in India. Developed by Pfizer,...
Continue Reading